Estradiol Cream: Uses, Dosage and What to Expect

Key Takeaways

• Vaginal estradiol cream may ease moderate to severe dryness, irritation and pain during sex after menopause.
• Estradiol also comes in forms that reach the whole body, such as patches, tablets and skin gels, which can help with hot flashes and night sweats.
• The 0.01% on a tube is the cream's strength. Your provider sets how much you use and how often.
• The approved cream is used more often at first, then less as you settle into a maintenance routine.
• A licensed provider reviews your history and labs before prescribing, then checks in with you every three months.

If dryness, irritation or discomfort during sex has crept in after menopause, you have plenty of company. In the REVIVE survey of 3,046 US women after menopause who had these symptoms, 55% reported vaginal dryness and 44% reported pain during sex. Estradiol cream is one of the prescriptions used to ease them.

Estradiol is a form of estrogen, and it comes in two broad kinds. Vaginal estradiol, including the cream, works right where you need it, on vaginal and vulvar tissue. Systemic estradiol, such as a patch or a tablet, reaches the whole body and is used for hot flashes.

How Can Estradiol Cream Help?

Estradiol vaginal cream is approved to treat moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. In everyday terms, that means vaginal dryness, irritation and pain during sex. Vulvar and vaginal atrophy is simply the clinical name for these changes.

• Relief from dryness: may help relieve vaginal dryness after menopause.
• Less irritation: may help ease vaginal irritation during everyday activities.
• More comfortable intimacy: may help reduce vaginal pain during sex.

Studies of a low-strength vaginal estradiol cream back this up. In one, women said they had less dryness after four weeks. In another, women said sex was less painful after eight weeks. Your provider will ask which symptoms bother you most and follow how they change.

Is Estradiol Cream the Same as Estradiol Gel?

Not always. Cream and gel describe texture. What matters more is where the estradiol is meant to work.

Vaginal Estradiol

This is the kind that works locally, right where dryness and discomfort happen. It comes as a cream, a gel, an insert or a ring, and these products are FDA-approved for moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. Vaginal estradiol cream is one of them.

Systemic Estradiol

This kind travels through your bloodstream and works throughout your body, which is why it's approved to treat moderate to severe hot flashes and night sweats. It comes as a tablet, a patch, a gel or spray for your skin, or an emulsion. In a study of Divigel, an estradiol gel applied to the skin, half the women using 1 mg had at least 8.4 fewer hot flashes a day after 12 weeks.

So a gel you rub on your thigh and a cream you use vaginally do different jobs, and your provider helps you match the product to what you want relief from.

Get started with estradiol cream

What Does the 0.01 Mean?

It's the cream's strength. Written out as 0.01%, it tells you how much estradiol is in each gram of cream.

How much your body absorbs also depends on how much you apply and how often, and your provider sets both. So two women can use the same strength on different routines, each one written for them.

How Do You Apply Estradiol Cream?

Your prescription comes with step-by-step instructions. Here's what to expect:

• An easy-to-measure dose: the approved cream comes with a marked applicator, so you know exactly how much to use.
• More often at first, then less: the approved label starts with a set number of weeks of more frequent use, then steps down to a lighter maintenance routine.
• Your amount is yours: a dose from a different vaginal estrogen product doesn't carry over to this one, so go by your own prescription.

If you'd like to change how much you use, how often or where you apply it, check with your provider first.

Side Effects and What to Watch For

You won't be on your own after you start. You'll have a check-in every three months and a review before every refill. A few things to know:

• Common side effects: the approved cream's patient information lists headache, breast pain, spotting, nausea, and burning, irritation or itching where the cream is used.
• If you have a uterus: progesterone helps protect the uterine lining when you take estrogen, so your provider will talk with you about whether you need it alongside your cream.
• What to tell your provider: any new vaginal bleeding, breast changes or side effects that bother you, so they can adjust your plan if needed.

What If Your Estradiol Cream Is Compounded?

If your provider prescribes a compounded cream, a licensed pharmacy mixes it specifically for you rather than in large batches. Your provider chooses the strength and how much to prescribe, and the pharmacy prepares it to that prescription. Your provider also reviews your care before every refill.

How Your Provider Tailors Your Plan

It begins with getting to know you. In your evaluation, a licensed provider looks at your health history, your symptoms and your lab results, then helps you decide whether estradiol is right for you and which form fits.

If vaginal dryness and discomfort are the only symptoms you want help with, a vaginal product like this cream is a natural place to start. The estradiol tablet label itself recommends considering vaginal products when vaginal and vulvar symptoms are the only reason for treatment.

From there, you'll check in every three months, and your provider adjusts your plan as you go.

Questions to Bring to Your Evaluation

A few questions help you get the most from your first visit. Which form of estradiol fits my symptoms, vaginal or systemic? What will my routine look like over the first few months? Should I take progesterone as well?

Your first step is an evaluation, where a licensed provider reviews your history and labs and decides whether estradiol cream is right for you.

Frequently Asked Questions

Is estradiol cream the same as estradiol gel?

Not always. Both words describe texture, not where the medicine works. A vaginal estradiol product acts on vaginal tissue, while an estradiol gel applied to the skin is designed to reach the bloodstream for hot flashes. Your provider confirms which one your prescription is for.

What does 0.01 mean on estradiol vaginal cream?

It's the strength: how much estradiol is in each gram of cream. How much you apply and how often come from your prescription.

What did studies of estradiol cream find?

The dryness result comes from a study of 576 women after menopause whose most bothersome symptom was moderate to severe vaginal dryness (248 analyzed on estradiol, 240 on a plain cream without estradiol). They used a 0.003% cream, 15 micrograms per application, daily for two weeks and then twice a week for 10 weeks. Dryness improved more with estradiol than with the plain cream at week 4, and again at weeks 8 and 12. By the end, the average change on a 0 to 3 severity scale was 1.4 points with estradiol and 1.2 with the plain cream.

The pain result comes from a separate study of sexually active women after menopause whose most bothersome symptom was moderate to severe pain during sex (239 analyzed on estradiol, 233 on plain cream). They used the same 0.003% cream daily for two weeks, then three times a week for 10 weeks. At week 8, the average change on a 0 to 3 severity scale was 1.5 points with estradiol and 1.2 with the plain cream, and the improvement was also seen at week 12.

These are group results, not a promise of when relief starts or that symptoms clear for every woman. Both studies used a 0.003% cream rather than a 0.01% or compounded cream, so results may differ with other formulations. The study routines aren't prescribing advice.

What did studies of estradiol gel on the skin find?

The result comes from the Divigel prescribing information, which reports a 12-week study in women after menopause who had at least 50 moderate to severe hot flashes a week. Among the 124 women using 1 mg a day, the median daily number of hot flashes fell by 8.35 (rounded to 8.4) from a starting median of 9.64, compared with a fall of 4.48 on a gel without estradiol. A median change means about half the women improved by at least that much; it isn't an average or the share of women helped. Divigel is applied to the skin of the upper thigh, not used vaginally, and the study dose isn't a prescribing instruction.

What does the boxed warning on estradiol cream say?

The approved estradiol vaginal cream label (Mylan, 0.01%) carries a boxed warning. For estrogen used alone, it says a woman with a uterus has a higher risk of endometrial cancer, and that adding a progestin has been shown to lower the risk of endometrial hyperplasia, a thickening of the uterine lining that may come before cancer. It asks that bleeding after menopause that keeps happening or comes back be checked, including with a sample of the uterine lining when needed. It also says estrogen, alone or with a progestin, shouldn't be used to prevent heart disease or dementia.

The warning then describes the Women's Health Initiative studies of daily estrogen pills in women 50 to 79. Estrogen alone was linked with higher risks of stroke and blood clots in the legs (deep vein thrombosis), and estrogen plus a progestin with higher risks of blood clots in the legs and lungs, stroke, heart attack and invasive breast cancer. A related memory study found a higher risk of probable dementia in women 65 and older on either treatment, and it isn't known whether this applies to younger women.

The label says these risks should be assumed to be similar for other doses and forms of estrogen, and that estrogen should be prescribed at the lowest effective dose for the shortest time that fits each woman's goals and risks. In November 2025, the FDA asked manufacturers to remove all of these statements from the boxed warning on vaginal estrogen products. Labels are being updated one at a time, and this one still carried the full warning when we last checked in October 2026. Other products, such as the Vagifem vaginal insert, carry their own label.

Did FDA remove the boxed warning from estradiol?

For vaginal estrogen products, the FDA has asked for it to come out. Its November 2025 request asks manufacturers to remove the cardiovascular, breast cancer and probable dementia statements from every menopausal hormone therapy, and the endometrial cancer statement from all but systemic estrogen-alone products. So systemic estrogen-alone products, such as estradiol patches and tablets, keep their endometrial cancer warning. Manufacturers are updating labels product by product, so the one on your own prescription is the one to go by.

Can a vaginal cream affect the rest of my body?

It can. The approved cream label says some estradiol may be absorbed into the body, so the warnings, precautions and side effects for estrogen taken by mouth also matter. Your provider weighs them when planning your care.

Do I need progesterone with estradiol cream?

If you have a uterus, ask about it at your first visit. Estrogen taken alone raises the chance of overgrowth of the uterine lining, and a progestogen such as progesterone is added to lower that risk. Your provider decides whether you need it with your cream.

Is compounded estradiol cream FDA-approved?

No. Compounded means a licensed pharmacy mixes the medicine for one person, and the FDA doesn't approve compounded medicines for safety, quality or how they're made. FDA's menopause page notes that many marketed products called "bioidentical hormones" are compounded drugs, which are not FDA-approved. A compounded cream doesn't come with FDA-approved prescribing information or a boxed warning of its own, so follow the directions on your prescription and pharmacy label.

Your provider chooses the product that fits you. LIV offers estradiol as a cream, patch, pill, vaginal gel and vaginal insert.

References

Archer, D. F., Kimble, T. D., Lin, F. D. Y., Battucci, S., Sniukiene, V., & Liu, J. H. (2018). A randomized, multicenter, double-blind, study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with vaginal dryness as the most bothersome symptom. Journal of Women's Health, 27(3), 231-237. https://pubmed.ncbi.nlm.nih.gov/29193980/

DailyMed, U.S. National Library of Medicine. (2010). Divigel (estradiol gel) 0.1%: Prescribing information (historical version, SPL version 2, published June 28, 2010). Read October 1, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22191eca-c98d-4a07-844e-11edb0f04b8d

Kingsberg, S. A., Wysocki, S., Magnus, L., & Krychman, M. L. (2013). Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. Journal of Sexual Medicine, 10(7), 1790-1799. https://pubmed.ncbi.nlm.nih.gov/23679050/

Kroll, R., Archer, D. F., Lin, Y., Sniukiene, V., & Liu, J. H. (2018). A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom. Menopause, 25(2), 133-138. https://pubmed.ncbi.nlm.nih.gov/28926514/

Mylan Pharmaceuticals Inc. (2026). Estradiol Vaginal Cream USP, 0.01%: prescribing information. DailyMed, U.S. National Library of Medicine. Label revised 2/2026, SPL version 10 published March 20, 2026; read August 5, 2026, rechecked October 1, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98770987-b313-4f2a-9aac-db0ab2068cc6

Novo Nordisk. (2024). Vagifem (estradiol vaginal inserts): prescribing information (revised 02/2024). DailyMed, U.S. National Library of Medicine. Read August 5, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5ad3cf6-dd96-4e64-af21-c1eee38d0b88

Teva Pharmaceuticals USA, Inc. (2024). Estradiol Tablets USP: prescribing information (Rev. D 2/2024). DailyMed, U.S. National Library of Medicine. Read October 1, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4936878-1643-4e7f-9b0d-e4957935aef2

U.S. Food and Drug Administration. (2025). FDA requests labeling changes related to safety information to clarify the benefit/risk considerations for menopausal hormone therapies. Drug Alerts and Statements, announced November 10, 2025; page content current as of February 12, 2026, read October 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations

U.S. Food and Drug Administration Office of Women's Health. (n.d.). Menopause. Women's Health Topics. Read October 1, 2026. https://www.fda.gov/consumers/womens-health-topics/menopause